Break free from the merry-go-round of eye drops. Experience SLT.
The Ellex
®
SLT Laser
FIRST CHOICE TECHNOLOGY FOR FIRST LINE THERAPY
Groundbreaking LiGHT Study Conclusions
Selective laser trabeculoplasty should be
offered as first-line treatment for open
angle glaucoma and ocular hypertension,
supporting a change in clinical practice.*
"
"
* LiGHT study | The Lancet. 393.10175
NIHR Biomedical Research Center at Moorfields Hospital , NHS Foundation
Trust, London, UK
Gus Gazzard, Evgenia Konstantakopoulou, David Garway-Heath, Anurag Garg,
Victoria Vickerstaff, Rachael Hunter, Gareth Ambler, Catey Bunce, Richard
Wormald, Neil Nathwani, Keith Barton, Gary Rubin, Marta Buszewicz
** Market Scope's 2018 Global Ophthalmic Laser Market Report
C O N TA C T E L L E X
®
TO D AY TO S C H E D U L E YO U R S LT
L A S E R T E C H N O L O G Y ( TA N G O
™
) E VA L U AT I O N.
t ( 8 5 5 ) 7 6 7 - 5 7 8 4
W W W. E L L E X . C O M
w
Global market
leadership in SLT
technology for a
reason.** Ellex
®
SLT is the doctor's
preferred choice!
